Molecular Biomarkers, Immune Mechanisms, and Next-Generation Immunodiagnostics in Autoimmune Diseases

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Biological Factors".

Deadline for manuscript submissions: 31 May 2027 | Viewed by 38

Editor


E-Mail Website
Guest Editor
King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia
Interests: autoimmune diseases; antimicrobial resistance; bone cancer

Special Issue Information

Dear Colleagues,

Autoimmune diseases comprise a diverse group of chronic disorders characterized by complex interactions among genetic susceptibility, immune dysregulation, environmental triggers, and molecular signaling pathways, ultimately leading to the breakdown of immune tolerance and the generation of pathogenic autoantibodies. Recent advances in molecular biology, molecular biomarker discovery, multi-omics technologies, and precision medicine have substantially expanded our understanding of autoimmune disease pathogenesis while enabling earlier diagnosis, improved patient stratification, disease monitoring, and personalized therapeutic decision-making.

This Special Issue aims to highlight recent advances in molecular biomarkers, immune mechanisms, and next-generation immunodiagnostics in autoimmune diseases. We welcome original research articles and comprehensive reviews addressing molecular biomarker discovery and validation, transcriptomics, proteomics, metabolomics, epigenomics, immune profiling, and other multi-omics approaches that provide novel insights into disease mechanisms and advance precision medicine. Studies describing innovative immunodiagnostic technologies, high-throughput autoantibody profiling, multiplex immunoassays, and their translational and clinical applications are also encouraged, with immunodiagnostics presented as an integral component of biomolecular research rather than its sole focus.

The Special Issue welcomes methodological advances, translational research, and state-of-the-art reviews covering the molecular mechanisms of autoimmunity, immune regulation, biomarker discovery and validation, precision medicine, and advanced immunodiagnostic approaches across a broad spectrum of autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, autoimmune thyroid diseases, Sjögren’s syndrome, inflammatory bowel diseases, and other immune-mediated disorders. By integrating fundamental biomolecular research with translational and clinical applications, this Special Issue aims to provide a comprehensive platform for advancing the understanding, diagnosis, and management of autoimmune diseases.

Dr. Yahya F. Jamous
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • autoimmune diseases
  • molecular biomarkers
  • immune mechanisms
  • multi-omics
  • next-generation immunodiagnostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop